FDA 483 - Medic Inc - July 27, 2021

An FDA inspection of Medic Inc, a regional blood center in Knoxville, TN, revealed a significant deficiency related to donor information. The firm failed to consistently obtain and confirm donor postal addresses for an 8-week contact period post-donation. This indicates a lapse in donor traceability procedures.